GLP Watchdog

Navio MD vs Shape Vantage

Neither Navio MD nor Shape Vantage has an FDA warning letter on record. No price lines up like for like. They share compounded tirzepatide injection, but Shape Vantage's $199.67 is a 3-month prepaid rate.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Navio MD / Shape Vantage

Navio MD logo

Navio MD

8.5/10

Shape Vantage logo

Shape Vantage

7.0/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$189/moCompounded tirzepatide injection
$199.67/moCompounded tirzepatide injection, 3-month prepaid plan
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Navio MDFull review
Visit Shape VantageFull review

Neither Navio MD nor Shape Vantage pays us. Links to them earn nothing. Scores: Navio MD 8.5, Shape Vantage 7.0. How we are paid

What the record shows

  1. 01

    Neither Navio MD nor Shape Vantage has an FDA warning letter on record.

  2. 02

    Navio MD names The Pharmacy Hub, a 503A pharmacy. Shape Vantage names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded tirzepatide injection, but Shape Vantage's $199.67 is a 3-month prepaid rate.

  4. 04

    Only Navio MD lists a price for brand-name tirzepatide pen.

  5. 05

    Navio MD lists all 50 states. Shape Vantage publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Navio MD

Shape Vantage

Compounded tirzepatide injection

$189/mo

$2,268 a year

$199.67/mo

3-month prepaid plan; not compared

Brand-name tirzepatide pen

$445/mo

$5,340 a year

Not sold or not priced

Read off each seller’s own pages. Navio MD: October 17, 2026. Shape Vantage: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Navio MD

8.5/10
  • Sells brand-name tirzepatide pen, which Shape Vantage does not price
  • Names its compounding pharmacy
Visit Navio MD

The case for Shape Vantage

7.0/10

The record gives Shape Vantage no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
  • Lowest price is a 3-month prepaid rate
Visit Shape Vantage

Scores

Navio MD 8.5 · Shape Vantage 7.0 out of 10. Six weighted parts.

Value25%

7.0A
vs
B
6.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

10.0A
vs
B
5.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Navio MD vs Shape Vantage: questions

Neither Navio MD nor Shape Vantage has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Navio MD names The Pharmacy Hub, a 503A pharmacy. Shape Vantage names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded tirzepatide injection, but Shape Vantage's $199.67 is a 3-month prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Neither Navio MD nor Shape Vantage pays us. Links to them earn nothing. Scores: Navio MD 8.5, Shape Vantage 7.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks